Skip to main content
Premium Trial:

Request an Annual Quote

Biochip Firm Lumera Registers for IPO; Stands to Gain $28 Million

NEW YORK, May 28 (GenomeWeb News) - Lumera, a majority owned subsidiary of Microvision, has filed a registration statement with the US Securities and Exchange Commission for a proposed initial public offering of 5 million shares of its common stock.

 

The move might net the company as much as $28 million based on pricing of between $5 to $6 a share. Lumera, which makes antennas for wireless communications and biochips, plans to trade on the Nasdaq SmallCap Market.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.